Trusted Resources to Learn More To stay current on weight control pharmacology, nurses can explore the following resources: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) American Gastroenterological Association Obesity Guidelines FDA Drug Safety and Medication Guides These sources provide reliable, evidence-based updates on weight management therapies, including GLP-1 receptor agonists
Because the hyperglycemic effect of glucagon receptor activation (hepatic glucose output) is effectively offset by the strong glucose-lowering activity of GLP-1R and GIPR co-activation (insulin secretion + glucagon suppression)
In fact, heres a quick extract from a previous article we wrote explaining how glutamine helps with leaky gut
G-CSF = Granulocyte-Colony-Stimulating Factor
On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulk drug substances list
To provide the highest level of service and availability to all patients, we require advance notice for cancellations or changes